Home » Topics » BioWorld Science

BioWorld Science
RSS

GlaxoSmithKline divulges new MYC, p300 and CREBBP inhibitors

April 1, 2019

Immunic patents IFN-gamma and IL-17 production inhibitors

April 1, 2019

BioThera Solutions recruiting participants in phase I study of BAT-8003

April 1, 2019

No pain, emotional gain due to newly identified mutation

April 1, 2019

Targeting hair loss outside the follicle

April 1, 2019

XenoTherapeutics initiates phase I study of Xeno-Skin

April 1, 2019

Alpelisib plus olaparib demonstrates promising activity and safety in phase I study

April 1, 2019

Merck & Co. presents novel AD-specific tau monoclonal antibody, MAFT-0617

April 1, 2019

MR-35602, a novel triple-activity compound with promising activity in model of AD

April 1, 2019

Proteo initiates clinical development of subcutaneous Elafin

April 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...